Equities

Avacta Group PLC

AVCT:LSE

Avacta Group PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)51.50
  • Today's Change2.00 / 4.04%
  • Shares traded1.97m
  • 1 Year change-57.96%
  • Beta1.8162
Data delayed at least 20 minutes, as of Sep 27 2024 17:07 BST.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments174226
Total Receivables, Net7.12104.61
Total Inventory2.591.680.19
Prepaid expenses1.701.762.47
Other current assets, total----1.28
Total current assets285635
Property, plant & equipment, net9.997.804.34
Goodwill, net17141.54
Intangibles, net14126.39
Long term investments4.082.98--
Note receivable - long term------
Other long term assets------
Total assets739347
LIABILITIES
Accounts payable3.732.490.56
Accrued expenses5.084.643.05
Notes payable/short-term debt34580
Current portion long-term debt/capital leases1.301.360.29
Other current liabilities, total0.591.290.47
Total current liabilities45684.37
Total long term debt5.953.751.41
Total debt42631.70
Deferred income tax0.320.56--
Minority interest------
Other liabilities, total------
Total liabilities51725.78
SHAREHOLDERS EQUITY
Common stock292725
Additional paid-in capital836255
Retained earnings (accumulated deficit)(90)(68)(39)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity222141
Total liabilities & shareholders' equity739347
Total common shares outstanding284266254
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.